Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Economic Development topic
No spam. Unsubscribe anytime.
City planners back adding research-lab and pharmaceutical manufacturing uses at 1320 Greenway Drive
Summary
Staff recommended approval to allow research laboratories and on-demand pharmaceutical product manufacturing (diagnostic PET-scan materials) at an undeveloped site at 1320 Greenway Drive; the applicant will present later in the evening.
Dylan, planning staff, presented a rezoning request to add research laboratories and manufacturing of pharmaceutical products as principal uses for a previously undeveloped parcel at 1320 Greenway Drive. Staff recommended approval and described the proposal as compatible with surrounding uses in the Walnut Hill Business Park and consistent with the city’s economic-development goals supporting life-sciences growth.
Commissioners asked about the nature of the pharmaceutical products and whether they were bulk drug manufacturing; staff said the applicant’s materials indicate production of diagnostic materials used in PET scans and on-demand custom diagnostic products (materials discussed in the packet and to be presented by the applicant later). No opposition was recorded in staff materials; the applicant is expected to present additional technical and safety details at the hearing stage.
